Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea
· Delayed Price · Currency is KRW 7,570.00
+20.00 (0.26%)
Apr 18, 2025, 3:30 PM KST
KRX:019170 Revenue
In the year 2024, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 221.09B KRW with 10.42% growth. Shinpoong Pharmaceutical Co.,Ltd had revenue of 55.26B in the quarter ending December 31, 2024, with 11.40% growth.
Revenue
221.09B
Revenue Growth
+10.42%
P/S Ratio
1.80
Revenue / Employee
271.28M
Employees
815
Market Cap
397.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | 197.75B | 8.03B | 4.23% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 68.13B |
| Peptron | 3.15B |
| LigaChem Biosciences | 125.90B |